• FirefoxInstall the new Firefox »
  •  Dow Down 0.59% Nasdaq Down 0.45%

    Agenus Inc. (AGEN)

    -NasdaqCM
    5.09 Down 0.07(1.36%) 12:56PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:5.16
    Open:5.11
    Bid:5.03 x 400
    Ask:5.04 x 1000
    1y Target Est:9.25
    Beta:1.05
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:5.00 - 5.21
    52wk Range:2.27 - 6.49
    Volume:389,604
    Avg Vol (3m):2,172,150
    Market Cap:360.16M
    P/E (ttm):N/A
    EPS (ttm):-0.71
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    AGENDown 1.36%360.16M
    ABPI 0.00%N/A
    DNDNDown 13.61%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):52.33
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.40
    Quarterly EPS Est (Mar-15) :-0.01
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Agenus Inc., an immunotherapy company, engages in discovering and developing innovative treatments for patients with cancer and other diseases. Its treatments focus on providing therapeutic benefit through modulation of immune function. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback